Company data (HQ, sector, founding year) comes from each startup’s own record. Funding figures are cross-referenced from the deals tracker’s most recent verified round for that company – not a lifetime-total field, since that field is not yet consistently populated across startup records.
| Big Picture Bio | Biotech | Pre-seed | 2026 | London, UK | €1.75M (last round) | no data |
| Eterna Regeneratives | Biotech | Seed | 2024 | London, UK | $3.5M-$4M (last round) | no data |
| CONNECTA Therapeutics | Biotech | Series A | 0 | Barcelona, ES | €3.1M (last round) | no data |
No rows match those filters
Clear the filters, or widen the scope.
The tracker did not respond
Try again in a few minutes.
This table shows the three companies with fresh, cross-referenced September 2026 rounds. 131 companies carry the biotech and pharma tag in total. CONNECTA Therapeutics is notable as a clinical-stage company already in Phase IIa trials, further along than most companies on this desk – a reminder that funding stage (Series A) does not always track clinical development stage in biotech.
Common questions
Does 'raised' mean total lifetime funding?
No – it shows the most recent verified round for each company. A lifetime-total field is in progress but not yet reliable across all startup records.
Why are only 3 companies shown out of 131 tagged?
These are the companies with a fresh September 2026 round cross-referenced to HQ and sector. sci2sci also raised this month but is not yet fully cross-referenced into this table.
Is stage in this table the same as clinical trial phase?
No. Stage refers to the funding round (pre-seed, seed, Series A). CONNECTA Therapeutics, for example, is a Series A company but already in Phase IIa clinical trials – the two scales measure different things.
Does Sesamers take payment for placement on this list?
No. Every company shown is included because it is a verified biotech or pharma startup, not because it paid for coverage.